@kakape Remember also the example of the Cuban Public Biotech, with four SARS-CoV-2 vaccine-candidates in clinical trial...Sub-unit, low cost, no profit and fully Public...These ones will be the real People's vaccines...(COVAX knows about it...)
@ProSyn@MazzucatoM@ElsTorreele I am sure one day you will also describe the Cuban Biotechnology, their therapeutic approaches, drugs and their SARS-CoV-2 vaccine-candidates...since 1960 with a brutal embargo, but with top level biopharmaceutics, Public, no profit, distributed around the World to poor Countries
You can keep bashing editors, referees, publishers, plan S and so on. But hear me out:
If 👏we👏don’t 👏change👏the👏reward👏system👏
Nothing👏will👏ever👏change 👏
This shitty publish or perish system is on us
Agenda : Our super PhD Glyco@Alps students will present their research on a symposium day open to all. Chemistry, material science, biology ... all #glycotime. This will be a zoom webinar open to everyone by registration
glycoalps.univ-grenoble-alpes.fr/glyco-alps/new…
@OttoemezzoTW@Aifa_ufficiale@lucatelese@Corriere@La7tv Menzionare i due vaccini-candidati Cubani in clinical trial, pubblici, no-profit, e totalmente unici nel suo genere, sarebbe giornalismo tantomeno "giusto"... chiedete in giro in Italia se si preferisce un vaccino Pfizer o uno cubano...eh già, esistono vaccini pubblici...a Cuba
A very clear and elegant analysis from our Director @BencomoVerez@FinlayInstituto, explaining @mesaredondacuba the advances of the two Cuban vaccine-candidates. In attached a very important slide on vaccine-safety and development, and the video link: youtu.be/blfZHzO-6jY
"Should its efforts succeed, the Caribbean island could become an important supplier to neighboring countries that might otherwise struggle to access vaccine supply as wealthy Western nations rush to secure doses..." Thanks @reuterssarah for the nice article and comments!